Javascript must be enabled to continue!
NANOG upregulates c‐jun oncogene expression through binding the c‐jun promoter
View through CrossRef
NANOG plays important roles in neoplastic processes. However, the molecular mechanism of NANOG in tumorigenesis remains to be elucidated. In this report, we demonstrated that forced expression of NANOG in 293 cells and cancer cells led to increased c‐Jun expression, whereas downregulation of endogenous NANOG significantly reduced c‐Jun expression in cancer cells. Dual luciferase reporter assays demonstrated that NANOG binds the c‐Jun proximal promoter and transactivates the c‐Jun gene. An ATTA consensus motif between the −160 and −268 region of the c‐Jun promoter was identified as the NANOG‐responsive element. Electromobility shift assay and chromatin immunoprecipitation results confirmed the direct binding of NANOG protein to the c‐Jun promoter in vitro and in vivo. NANOG directly bound c‐Jun protein as shown by GST pulldown and immunoprecipitation assays. Taking these findings together, we conclude that c‐Jun is a direct target gene of NANOG and that c‐Jun protein may be a novel co‐activator of NANOG in cancer cells. We suggest the possibility that NANOG may play a significant role in carcinogenesis via its activation of c‐Jun expression. © 2014 Wiley Periodicals, Inc.
Title: NANOG upregulates c‐jun oncogene expression through binding the c‐jun promoter
Description:
NANOG plays important roles in neoplastic processes.
However, the molecular mechanism of NANOG in tumorigenesis remains to be elucidated.
In this report, we demonstrated that forced expression of NANOG in 293 cells and cancer cells led to increased c‐Jun expression, whereas downregulation of endogenous NANOG significantly reduced c‐Jun expression in cancer cells.
Dual luciferase reporter assays demonstrated that NANOG binds the c‐Jun proximal promoter and transactivates the c‐Jun gene.
An ATTA consensus motif between the −160 and −268 region of the c‐Jun promoter was identified as the NANOG‐responsive element.
Electromobility shift assay and chromatin immunoprecipitation results confirmed the direct binding of NANOG protein to the c‐Jun promoter in vitro and in vivo.
NANOG directly bound c‐Jun protein as shown by GST pulldown and immunoprecipitation assays.
Taking these findings together, we conclude that c‐Jun is a direct target gene of NANOG and that c‐Jun protein may be a novel co‐activator of NANOG in cancer cells.
We suggest the possibility that NANOG may play a significant role in carcinogenesis via its activation of c‐Jun expression.
© 2014 Wiley Periodicals, Inc.
Related Results
Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18
Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18
Persistent infections with some types of human papillomavirus (HPV) constitute the major etiological factor for cervical cancer development. Nanog, a stem cell transcription factor...
Molecular prognostication of thyroid tumors : with special focus on TERT
Molecular prognostication of thyroid tumors : with special focus on TERT
<p dir="ltr">Thyroid carcinoma is the most common endocrine malignancy, with its incidence steadily increasing worldwide. These tumors can be challenging to diagnose, and tre...
Molecular prognostication of thyroid tumors : with special focus on TERT
Molecular prognostication of thyroid tumors : with special focus on TERT
<p dir="ltr">Thyroid carcinoma is the most common endocrine malignancy, with its incidence steadily increasing worldwide. These tumors can be challenging to diagnose, and tre...
Molecular Mechanisms Regulating BAFF and APRIL Receptor Expression in B Cells: Promoter Structure and Epigenetics
Molecular Mechanisms Regulating BAFF and APRIL Receptor Expression in B Cells: Promoter Structure and Epigenetics
Abstract
Throughout differentiation, mature B cells express distinct combinations of the BAFF and APRIL receptors, BAFF-R, TACI, and BCMA. The patterns of B lineage ...
Abstract 2313: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1
Abstract 2313: Dynamic expression of 5-alpha reductase 2 in aging prostate is regulated by DNA methyltransferase 1
Abstract
BACKGROUND:
5-alpha reductase type 2 (SRD5A2), an enzyme that is critical for prostatic development and growth, is utilized as an inhibitory ...
Correlated Expression of Glutathione S‐Transferase‐π and c‐Jun or Other Oncogene Products in Human Squamous Cell Carcinomas of the Head and Neck: Relevance to Relapse after Radiation Therapy
Correlated Expression of Glutathione S‐Transferase‐π and c‐Jun or Other Oncogene Products in Human Squamous Cell Carcinomas of the Head and Neck: Relevance to Relapse after Radiation Therapy
The expression of glutathione S‐transferase (GST)‐π and four oncogene products, c‐Jun, c‐Fos, c‐H‐Ras, and c‐Myc, in human squamons cell carcinomas of the head and neck was investi...
Abstract 176: The Evolution of NANOGP8 and its possible roles in tumorigenesis
Abstract 176: The Evolution of NANOGP8 and its possible roles in tumorigenesis
Abstract
Human NANOG gene is located in Chromosome 12p13. It is a transcription factor in embryonic stem cells. There are 11 NANOG pseudogenes in human genome. NANOG...
Profiling YB-1 responsive genes in basal-like breast cancer cells by ChIP-on-chip reveals direct binding to PIK3CAs
Profiling YB-1 responsive genes in basal-like breast cancer cells by ChIP-on-chip reveals direct binding to PIK3CAs
Purpose: Basal-like breast cancers (BLBC) are typically very aggressive and they are also prone to a high rate of recurrence. We recently identified the transcription factor Y-box ...

